Clinical Paper: Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides
![article-placeholder](/sites/default/files/2023-04/article-placeholder_3.jpg)
An Australian based open-label, non-randomized, multicenter trial by Gold et al. 2022 uses an amino acid-based formula (AAF) supplemented with two human milk oligosaccharides (HMO) to demonstrate normal growth, good tolerance and significant microbiome shift in infants with a cow’s milk protein allergy (CMPA).